ASND - Ascendis Pharma AS - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ASND is currently covered by 14 analysts with an average price target of $291.33. This is a potential upside of $64.4 (17.76%) from yesterday's end of day stock price of $247.4.

Ascendis Pharma AS's activity chart (see below) currently has 287 price targets and 217 ratings on display. The stock rating distribution of ASND is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.68% with an average time for these price targets to be met of 481.7 days.

Highest price target for ASND is $355, Lowest price target is $254, average price target is $291.33.

Most recent stock forecast was given by ELIANA MERLE from BARCLAYS on 13-Aug-2026. First documented stock forecast 22-Feb-2015.

Best performing analysts who are covering ASND - Ascendis Pharma AS:

Andreas Argyrides Paul Choi Derek Archila Joshua Schimmer Liana Moussatos Alex Thompson

Currently out of the existing stock ratings of ASND, 30 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Jan-2025

$329

$80.5 (32.39%)

$345

Buy Since 15-Apr-2025

$290

$41.5 (16.70%)

$280

Buy Since 03-Sep-2024

$341

$92.5 (37.22%)

$325

Buy Since 02-Jul-2025

$275

$26.5 (10.66%)

$250

Buy Since 20-Apr-2020

$355

$94.25 (36.15%)

$243

Show more analysts

Please expand the browser size to see the chart

What is ASND (Ascendis Pharma AS) average time for price targets to be met?

On average it took 481.7 days on average for the stock forecasts to be realized with a an average price target met ratio 85.68

Which analyst has the current highest performing score on ASND (Ascendis Pharma AS) with a proven track record?

Which analyst has the most public recommendations on ASND (Ascendis Pharma AS)?

has 0 price targets and 0 ratings on ASND

Which analyst is the currently most bullish on ASND (Ascendis Pharma AS)?

David Lebowitz with highest potential upside - $106.5

Which analyst is the currently most reserved on ASND (Ascendis Pharma AS)?

Tiago Fauth with lowest potential downside - -$150.28

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?